Pulsed cavitational ultrasound therapy

Patent metadata

Field	Value
Publication number	US-9642634-B2
Application number	US-201113241076-A
Country	US
Kind code	B2
Filing date	Sep 22, 2011
Priority date	Sep 22, 2005
Publication date	May 9, 2017
Grant date	May 9, 2017

Abstract

Therapy methods using pulsed cavitational ultrasound therapy can include the subprocesses of initiation, maintenance, therapy, and feedback of the histotripsy process, which involves the creation and maintenance of ensembles of microbubbles and the use of feedback in order to optimize the process based on observed spatial-temporal bubble cloud dynamics. The methods provide for the subdivision or erosion of tissue, liquification of tissue, and/or the enhanced delivery of therapeutic agents. Various feedback mechanisms allow variation of ultrasound parameters and provide control over the pulsed cavitational process, permitting the process to be tuned for a number of applications. Such applications can include specific tissue erosion, bulk tissue homogenization, and delivery of therapeutic agents across barriers.

First claim

What is claimed is:

1. A method for controlled mechanical sub-division of soft tissue comprising:
de-initiating a non-treatment portion of the soft tissue to increase a cavitation threshold from a first threshold to a second threshold in said non-treatment portion of the soft tissue;
outputting an initiation pulse sequence at a treatment portion of the soft tissue;
detecting initiation of a bubble cloud in said treatment portion of the soft tissue in response to said initiation pulse sequence;
outputting a bubble cloud maintenance and sustaining pulse sequence at said treatment portion; and
outputting a therapy pulse sequence which generates and interacts with said bubble cloud to at least partially fractionate the soft tissue in said treatment portion.

2. The method according to claim 1 wherein said de-initiating said non-treatment portion of the soft tissue comprises de-initiating said non-treatment portion of the soft tissue using a deleting pulse sequence at a pulse intensity less than said first threshold.

3. The method according to claim 1 wherein said de-initiating a non-treatment portion of the soft tissue and said outputting an initiation pulse sequence are performed simultaneously.

4. The method according to claim 1 , further comprising: detecting cessation of said bubble cloud.

5. The method according to claim 4 , further comprising:
re-outputting said initiation pulse sequence in response to said cessation of said bubble cloud.

6. The method according to claim 4 , further comprising:
re-outputting said bubble cloud sustaining pulse sequence prior to said cessation of said bubble cloud.

7. The method according to claim 1 wherein said outputting an initiation pulse sequence comprises outputting an initiation pulse sequence at a frequency equal to a frequency of at least one of said bubble cloud sustaining pulse sequence and said therapy pulse sequence.

8. The method according to claim 1 wherein said outputting an initiation pulse sequence comprises outputting an initiation pulse sequence operable to create at least one of a vapor cloud or a plasma cloud.

9. The method according to claim 1 wherein said outputting an initiation pulse sequence comprises outputting an initiation pulse sequence causing an ionizing radiation bubble chamber effect.

10. The method according to claim 1 wherein said outputting an initiation pulse sequence comprises mechanically injecting cavitation nuclei.

11. The method according to claim 10 wherein said mechanically injecting cavitation nuclei comprises mechanically injecting cavitation nuclei intravascularly.

12. The method according to claim 10 wherein said mechanically injecting cavitation nuclei comprises mechanically injecting cavitation nuclei into a therapy volume.

13. The method according to claim 1 , further comprising:
targeting a therapeutic substance at a predetermined location in the soft tissue to enhance enucleation of dissolved gases in the soft tissue.

14. The method according to claim 13 wherein said targeting a therapeutic substance comprises targeting a therapeutic substance selected from the group consisting essentially of enzymes, proteins, and proto-bubble droplets.

15. The method according to claim 1 wherein said outputting an initiation pulse sequence comprises mechanically stimulating the soft tissue to generate cavitation nuclei.

16. The method according to claim 1 wherein said outputting an initiation pulse sequence comprises thermally stimulating the soft tissue to generate vapor nuclei.

17. The method according to claim 1 , further comprising:
interleaving said bubble cloud sustaining pulse sequence and said therapy pulse sequence.

18. The method according to claim 1 wherein said outputting a bubble cloud sustaining pulse sequence comprises optically stimulating said bubble cloud to generally maintain said bubble cloud.

19. The method according to claim 1 wherein said outputting a bubble cloud sustaining pulse sequence comprises stimulating said bubble cloud via ionizing radiation to generally maintain said bubble cloud.

20. The method according to claim 1 wherein said outputting a bubble cloud sustaining pulse sequence comprises mechanically stimulating said bubble cloud to generally maintain said bubble cloud.

21. The method according to claim 1 wherein said outputting a bubble cloud sustaining pulse sequence comprises thermally stimulating said bubble cloud to generally maintain said bubble cloud.

Assignees

• Cain Charles A
• Xu Zhen
• Fowlkes J Brian
• Hall Timothy L
• Roberts William W
• Univ Michigan Regents

Inventors

• Cain Charles A
• Xu Zhen
• Fowlkes J Brian
• Hall Timothy L
• Roberts William W

Classifications

• A61B2017/00154

  pulsed · CPC title

• A61B2017/22088

  ultrasound absorbing, drug activated by ultrasound · CPC title

• A61B2017/00172

  Pulse trains, bursts, intermittent continuous operation · CPC title

• A61B8/485

  involving measuring strain or elastic properties · CPC title

• A61B2017/22089

  Gas-bubbles · CPC title